COVID-19 control strategies and intervention effects in resource limited settings: A modeling study.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2021
2021
Historique:
received:
29
04
2020
accepted:
18
05
2021
entrez:
2
6
2021
pubmed:
3
6
2021
medline:
29
6
2021
Statut:
epublish
Résumé
Many countries with weaker health systems are struggling to put together a coherent strategy against the COVID-19 epidemic. We explored COVID-19 control strategies that could offer the greatest benefit in resource limited settings. Using an age-structured SEIR model, we explored the effects of COVID-19 control interventions-a lockdown, physical distancing measures, and active case finding (testing and isolation, contact tracing and quarantine)-implemented individually and in combination to control a hypothetical COVID-19 epidemic in Kathmandu (population 2.6 million), Nepal. A month-long lockdown will delay peak demand for hospital beds by 36 days, as compared to a base scenario of no intervention (peak demand at 108 days (IQR 97-119); a 2 month long lockdown will delay it by 74 days, without any difference in annual mortality, or healthcare demand volume. Year-long physical distancing measures will reduce peak demand to 36% (IQR 23%-46%) and annual morality to 67% (IQR 48%-77%) of base scenario. Following a month long lockdown with ongoing physical distancing measures and an active case finding intervention that detects 5% of the daily infection burden could reduce projected morality and peak demand by more than 99%. Limited resource settings are best served by a combination of early and aggressive case finding with ongoing physical distancing measures to control the COVID-19 epidemic. A lockdown may be helpful until combination interventions can be put in place but is unlikely to reduce annual mortality or healthcare demand.
Identifiants
pubmed: 34077483
doi: 10.1371/journal.pone.0252570
pii: PONE-D-20-12495
pmc: PMC8172066
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0252570Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
N Engl J Med. 2020 Mar 26;382(13):1199-1207
pubmed: 31995857
Epidemics. 2015 Mar;10:49-53
pubmed: 25843383
Science. 2020 May 8;368(6491):
pubmed: 32234805
Lancet Infect Dis. 2020 Jun;20(6):669-677
pubmed: 32240634
Lancet Infect Dis. 2020 May;20(5):553-558
pubmed: 32171059
Math Biosci Eng. 2013 Oct-Dec;10(5-6):1475-97
pubmed: 24245626
Lancet. 2020 Feb 15;395(10223):483
pubmed: 32061284
Lancet Public Health. 2020 May;5(5):e261-e270
pubmed: 32220655
JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
Lancet Infect Dis. 2020 Jun;20(6):678-688
pubmed: 32213332
BMC Med. 2009 Jun 22;7:30
pubmed: 19545404
Cochrane Database Syst Rev. 2020 Apr 8;4:CD013574
pubmed: 32267544
Lancet Glob Health. 2020 Apr;8(4):e488-e496
pubmed: 32119825
N Engl J Med. 2020 Apr 9;382(15):e28
pubmed: 32187460
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
PLoS One. 2017 Jun 14;12(6):e0179315
pubmed: 28614365
Lancet. 2020 Mar 28;395(10229):1015-1018
pubmed: 32197103
PLoS Comput Biol. 2017 Sep 12;13(9):e1005697
pubmed: 28898249
Lancet. 2020 Mar 7;395(10226):764-766
pubmed: 32105609
Nature. 2020 Mar 18;:
pubmed: 32203363
Lancet. 2020 Mar 14;395(10227):841-842
pubmed: 32113508
Nature. 2006 Jul 27;442(7101):448-52
pubmed: 16642006
Science. 2005 Aug 12;309(5737):1083-7
pubmed: 16079251
Nat Med. 2020 May;26(5):672-675
pubmed: 32296168
Proc Natl Acad Sci U S A. 2008 Mar 25;105(12):4639-44
pubmed: 18332436
JAMA. 2020 Apr 14;323(14):1341-1342
pubmed: 32125371